Company intelligence / Profile preview

Monomer Bio

Pacifica, California, United Statesmonomerbio.com ↗

Ownership: Private
Development stage: Commercial

Overview

Monomer Bio has developed an AI-powered laboratory automation platform that integrates with standard lab equipment to automate cell culture workflows. The system enables real-time monitoring, data analysis, protocol optimization, and deep learning applications for imaging data. Early adopters in biotech have reported significant increases in productivity—e.g., Indee Labs saw an eightfold increase in key cell production after implementation. The company is focused on accelerating discovery for clients working on advanced therapies like iPSC-derived organoids and immune cells.

Modalities: DeviceSoftware platform
Industry: Drug Discovery Services

Partnerships

Indee Labs

Beyond the preview

Go deeper on Monomer Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Monomer Bio.

Explore the full profile